Sanofi’s Head of Rare Diseases Discusses Future Developments on Rare Disease Day 2025

On February 28, 2025, in observance of Rare Disease Day, European Pharmaceutical Review (EPR) conducted an exclusive interview with Christina Gkousgkouni, who leads the Rare Diseases division for Central South Europe at Sanofi. The discussion highlighted the evolving landscape and future prospects within the rare disease sector.

Rare Disease Day is commemorated globally to raise awareness about rare diseases and their impact on patients’ lives. This year’s theme emphasizes preparing for new advancements in treatment and management.

During the interview, Gkousgkouni shared insights into upcoming innovations and strategies aimed at enhancing patient care and accelerating drug development for rare conditions. She emphasized the importance of collaboration among researchers, healthcare providers, and policymakers to foster a supportive environment for breakthroughs in this specialized field.

The full details of this enlightening conversation can be found on EPR’s website under the title “Preparing for a New Era in the Rare Disease Sector.”

Published: February 28, 2025

Newsflash | Powered by GeneOnline AI

Related posts:

PepGen’s New Drug Candidate Shows Promising Results in Treating Rare Muscle Disorder Breakthrough AI Tool Identifies Life-Saving Medication for Rare Disease Patient Roger Perlmutter’s New Biotech Startup Secures $350 Million in Funding Imaging Discovery Promises Faster Drug Development

Author

Mark Chiang

Ph.D in Biomedical Informatics Head of AI at GeneOnline